Noticias Celltex
An Update from Celltex Therapeutics Regarding COVID-19
We have been closely monitoring the guidelines set forth from the Centers for Disease Control (CDC) and the World Health Organization (WHO) in response to COVID-19. The safety and health of our team, clients and community is extremely important to us and because of this, we are taking proper precautions in our corporate office and lab environment.
Celltex has been taking extra safety measures in the lab to ensure all staff and operations are adhering to top safety standards. The following precautions in our lab have been implemented:
- All incoming supplies are being thoroughly disinfected before entering the workplace.
- All supplies and materials have been ordered to keep the lab fully operations.
- We are continuing to adhere to cGMP guidelines that are already in place to eliminate the spread of contaminants (including COVID-19).
- Our lab technicians complete a deep-clean of the lab on a daily basis.
- A COVID-19 screening test has been added to every blood test panel completed with LabCorp. If the test is positive, the sample is not allowed to enter our facilities.
Noticias más recientes
Desarrollo de terapias COVID-19 a partir de tejidos de parto y sangre del cordón
Celltex Therapeutics Corporation se mencionó en la publicación Stem Cell Journals como uno de los cinco ensayos de terapia con células madre más grandes que utilizan MSC para combatir el COVID en un artículo titulado “Desarrollo de terapias COVID-19 a partir de tejidos de parto y sangre del cordón umbilical”.
Leer másCompañía de Houston obtiene luz verde para estudiar sus propias células madre para prevenir COVID-19
Noticias prometedoras de Houston de una empresa que obtuvo la autorización de la FDA para intentar usar las propias células madre de una persona para prevenir el COVID-19. Celltex Therapeutics Corporation también espera que las células madre ayuden a tratar algunos de los casos más graves.
Leer más